- Home
- GNFT vs ARAY Comparison
GNFT vs ARAY Comparison
Compare GNFT & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- ARAY
- Stock Information
- Founded
- GNFT 1999
- ARAY 1990
- Country
- GNFT France
- ARAY United States
- Employees
- GNFT N/A
- ARAY N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- ARAY Medical/Dental Instruments
- Sector
- GNFT Health Care
- ARAY Health Care
- Exchange
- GNFT Nasdaq
- ARAY Nasdaq
- Market Cap
- GNFT 172.2M
- ARAY 180.0M
- IPO Year
- GNFT 2019
- ARAY 2007
- Fundamental
- Price
- GNFT $3.47
- ARAY $2.24
- Analyst Decision
- GNFT Strong Buy
- ARAY Strong Buy
- Analyst Count
- GNFT 1
- ARAY 1
- Target Price
- GNFT $13.00
- ARAY $9.00
- AVG Volume (30 Days)
- GNFT 6.9K
- ARAY 669.1K
- Earning Date
- GNFT 09-19-2024
- ARAY 01-29-2025
- Dividend Yield
- GNFT N/A
- ARAY N/A
- EPS Growth
- GNFT N/A
- ARAY N/A
- EPS
- GNFT 0.47
- ARAY N/A
- Revenue
- GNFT $86,225,222.00
- ARAY $444,204,000.00
- Revenue This Year
- GNFT $145.20
- ARAY $6.64
- Revenue Next Year
- GNFT N/A
- ARAY $5.69
- P/E Ratio
- GNFT $7.23
- ARAY N/A
- Revenue Growth
- GNFT 175.45
- ARAY N/A
- 52 Week Low
- GNFT $3.33
- ARAY $1.40
- 52 Week High
- GNFT $6.42
- ARAY $2.99
- Technical
- Relative Strength Index (RSI)
- GNFT 31.89
- ARAY 60.03
- Support Level
- GNFT $3.35
- ARAY $2.04
- Resistance Level
- GNFT $3.57
- ARAY $2.34
- Average True Range (ATR)
- GNFT 0.11
- ARAY 0.15
- MACD
- GNFT 0.01
- ARAY 0.03
- Stochastic Oscillator
- GNFT 21.82
- ARAY 82.76
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.